Plenty of high school students plan to make careers out of coding when they graduate from college. And plenty of other students are probably planning careers as cancer-research scientists. But… Read More
Rob Relyea set out to find information to help his wife. A longtime Microsoft engineer, Relyea had more than 28 years of experience at the company using technology to solve… Read More
At home and at work, Justine Dell’Aringa is up for a challenge. The scientific associate director of Translational Research for Bristol Myers Squibb’s Immuno-Oncology and Cell Therapy Thematic Research Center… Read More
Concure Oncology has raised $2 million in new funding, helping to fuel growth for the Mercer Island, Wash.-based startup and get more clinicians trained in its innovative radiation treatment for… Read More
Seattle biotech company Phase Genomics announced Wednesday that it received two National Institutes of Health (NIH) grants totaling $3.9 million. The funding, which runs for three years, will help pay… Read More
Dr. Thomas Lynch is in his first week as the new leader of the Fred Hutchinson Cancer Research Center, but he already has a four-point plan to help guide the… Read More
Why do some strings of genetic code remain virtually unchanged despite tens of millions of years of evolutionary divergence? A newly published study that takes advantage of the gene-editing technique… Read More
Researchers at Seattle’s Fred Hutchinson Cancer Research Center have demonstrated the effectiveness of a new method for getting immune cells to fight solid tumors — by spreading them like jam… Read More
New funding: Concure Oncology is raising investment for its Breast Microseed treatment, which helps to prevent breast cancer from recurring. A new SEC filing reveals a $3 million cash infusion… Read More
TerraPower, the nuclear research venture founded by Bill Gates, is joining with Isotek Systems and the U.S. Department of Energy in a public-private partnership aimed at turning what otherwise would… Read More
The rise of therapies that target tumors based on their genetic profile is revolutionizing how we treat cancer. It’s also creating a data overload. Around 17 million people are diagnosed… Read More
Shares of cancer drug maker Seattle Genetics soared more than 17 percent Monday morning following positive results for a new drug that fights aggressive breast cancers. Tucatinib is a daily… Read More
Maryn Sage remembers the words she heard on the day she learned that her 16-year-old son, Jedd Feliciano, was cancer-free. “His marrow’s clean,” the doctor told her over the phone,… Read More
Seattle startup SEngine Precision Medicine has raised $5.1 million in fresh funding as it looks to commercialize a platform that can match cancer patients to the right drug and aid… Read More
Navigating Cancer, a Seattle startup that makes software to help providers and patients manage cancer treatment, landed $26 million in a Series D investment round. The funding was led by… Read More
Video games are surrounded by a stigma that they are inherently bad from a mental health perspective. This negative perception led to the World Health Organization classifying video game addiction… Read More
Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering. The company signed a 100,000 square-foot lease, tripling its current… Read More
Vancouver, B.C.-based Aquinox Pharmaceuticals is set to buy Neoleukin Therapeutics, a Seattle startup that launched out of the University of Washington just eight months ago. Aquinox is paying for the… Read More
Seattle Genetics sold more than 8 million shares in a stock offering that brought in $575 million for the company before expenses and commissions. The Bothell, Wash.-based drugmaker said the… Read More
The question of why immunotherapy eradicates cancer in some people while having little effect on the majority of patients has vexed scientists since the introduction of the treatment. Now, researchers… Read More
Cancer drugmaker Seattle Genetics reported stronger-than-expected revenues for the second quarter as its stock rose more than 8 percent in after-hours trading. The Bothell, Wash.-based drugmaker posted $218 million in… Read More
Microsoft is teaming up with leading medical research organizations to create a shared network of research data in the Pacific Northwest. Dubbed the Cascadia Data Discovery Initiative (CDDI), the goal… Read More
Kristin Anderson has already fought cancer in more ways than one. She’s a cancer survivor whose battle with breast cancer started when she was just 28 years old and pursuing… Read More
Biotech giant Amgen is putting up the money to fund three research projects in partnership with the University of Washington’s Institute for Protein Design (IPD). Amgen declined to disclose the… Read More
The Fred Hutchinson Cancer Research Center in Seattle wants to raise awareness about colorectal health in underserved communities across Washington state. But first it needs your help in naming a… Read More
The Fred Hutchinson Cancer Research Center has a historic new signpost on Seattle’s Lake Union. The institution has started adding its name on the Lake Union Steam Plant’s iconic smokestacks… Read More
Blaze Bioscience, a Seattle-based biotech company that’s using a protein borrowed from scorpion venom to make cancerous tumors glow, has passed its first clinical trial with flying colors and is… Read More
For most patients, a diagnosis of stage 4 non-small cell lung cancer comes with a dire prognosis. But for patients with specific mutations that cause the disease, there are potentially… Read More
Two months after Merck acquired Seattle-based biotech Immune Design for $300 million, the president of Merck Research Laboratories, Roger Perlmutter, says the city’s life science community has plenty more to… Read More
Seattle-based startup Navigating Cancer has raised $12 million for its digital platform that lets cancer doctors interact with their patients. The round drew investments from existing investors including Merck Global… Read More
